Cervical Cancer – Epidemiology – Mature Markets
Clarivate Epidemiology’s coverage of cervical cancer comprises epidemiological estimates of key patient populations in 45 countries worldwide. We report both the incidence and prevalence of cervical cancer for each country, as well as annualized case counts projected to the national population.
Most patient populations are forecast over a period of 20 years for the major mature pharmaceutical markets and 10 years for the other countries covered in this report.
Clarivate Epidemiology’s cervical cancer forecast will answer the following question:
- How will demographic trends, such as population aging and improving life expectancy, affect the epidemiology of cervical cancer over the forecast period?
All forecast data are available on the Clarivate Insights Platform in tabular format, with options to download to MS Excel. All populations are accompanied by a comprehensive description of the methods and data sources used, with hyperlinks to external sources. A summary evidence table generated as part of our systematic review of the epidemiological literature is also provided for full transparency into research and methods.
Clarivate Epidemiology forecasts 13 cervical cancer patient populations, as follows:
- Diagnosed incident cases of cervical cancer.
- Resectable non-drug-treatable prevalent cases of cervical cancer.
- Resectable drug-treatable prevalent cases of cervical cancer.
- Diagnosed recurrent incident cases of cervical cancer.
- Diagnosed prevalent cases of cervical cancer.
- Unresectable drug-treatable prevalent cases of cervical cancer.
- Diagnosed incident cases of stage IA cervical cancer.
- Diagnosed incident cases of stage IB cervical cancer.
- Diagnosed incident cases of stage IIA cervical cancer.
- Diagnosed incident cases of stage IIB cervical cancer.
- Diagnosed incident cases of stage III cervical cancer.
- Diagnosed incident cases of stage IVA cervical cancer.
- Diagnosed incident cases of stage IVB cervical cancer.
- … and more (details available on request).
Note: Coverage may vary by country.
Table of contents
- Cervical Cancer - Epidemiology - Mature Markets
- Epidemiology Data
- Methods
- Literature review (studies included in/excluded from the analyses of cervical cancer)
- Diagnosed incident cases
- Stage distribution of cervical cancer
- Recurrent incident cases of cervical cancer
- Diagnosed prevalent cases
- Drug-treatable populations
- Risk / protective factors applied to disease forecast models
- Reference Materials
